Lv4
406 积分 2020-09-16 加入
Global landscape of PROTAC: Perspectives from patents, drug pipelines, clinical trials, and licensing transactions
9小时前
已完结
A modern strategy for digital real-time release testing in continuous tablet manufacturing
11小时前
已完结
A modern strategy for digital real-time release testing in continuous tablet manufacturing
14小时前
已完结
Calculating qualified non-mutagenic impurity levels: Harmonization of approaches
14小时前
已完结
Deriving acceptable limits for non-mutagenic impurities in medicinal products – Durational adjustments
14小时前
已完结
Regulatory Toxicology and Pharmacology New limits proposed for the management of non-mutagenic impurities
14小时前
已完结
Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products
6天前
已完结
Biopredictive Dissolutions for Conventional Oral IR, MR and Non-Oral Formulations – Current Status and Future Opportunities
12天前
已关闭
Journey of PROTAC: From Bench to Clinical Trial and Beyond
12天前
已完结
Improved dissolution of an enteric polymer and its amorphous solid dispersions by polymer salt formation
22天前
已完结
皖公网安备34019202002308
